Study Evaluating PSI-697 in Patients With Scleritis

Summary

To evaluate the safety of an orally administered single dose of PSI-697 in subjects with scleritis, as a model of inflammatory disease. To evaluate by in vivo confocal microscopy (IVCM) the effect of a single dose of PSI-697 on leukocyte rolling in the scleral blood vessels of subjects with scleritis.

Timeline

Start

2006-09

Primary completion

—

Completion

2007-04

Drugs

Indications